These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6104961)

  • 1. Incorporation of radiolabel from [1-14C]5-hydroperoxy-eicosatetraenoic acid into slow reacting substance.
    Parker CW; Koch D; Huber MM; Falkenhein SF
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1037-43. PubMed ID: 6104961
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway.
    Falkenhein SF; MacDonald H; Huber MM; Koch D; Parker CW
    J Immunol; 1980 Jul; 125(1):163-8. PubMed ID: 6103910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
    Jakschik BA; Falkenhein S; Parker CW
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4577-81. PubMed ID: 22078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow reacting substance (SRS) from ionophore A23187-stimulated human leukemic basophils. I. Evidence for a precursor role of arachidonic acid and initial purification.
    Yecies LD; Wedner HJ; Parker CW
    J Immunol; 1979 Dec; 123(6):2814-6. PubMed ID: 41019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-reacting substances and their formation by a lipoxygenase pathway.
    Piper PJ; Samhoun MN; Tippins JR; Morris HR; Taylor GW
    Agents Actions; 1980 Dec; 10(6):541-7. PubMed ID: 6115549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic assembly of slow reacting substance.
    Jakschik BA; Lee LH
    Nature; 1980 Sep; 287(5777):51-2. PubMed ID: 6106162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positional specificity of a reticulocyte lipoxygenase. Conversion of arachidonic acid to 15-S-hydroperoxy-eicosatetraenoic acid.
    Bryant RW; Bailey JM; Schewe T; Rapoport SM
    J Biol Chem; 1982 Jun; 257(11):6050-5. PubMed ID: 6804460
    [No Abstract]   [Full Text] [Related]  

  • 8. New group of leukotrienes formed by initial oxygenation at C-15.
    Rådmark O; Lundberg U; Jubiz W; Malmsten C; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():61-70. PubMed ID: 6124099
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187.
    Parker CW; Falkenhein SF; Huber MM
    Prostaglandins; 1980 Nov; 20(5):863-86. PubMed ID: 6110221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
    Orning L; Hammarström S; Samuelsson B
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2014-7. PubMed ID: 6103542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biological transformations of 15-Ls-hydroperoxy-5,8,11,13-eicosatetraenoic acid.
    Hamberg M; Herman CA; Herman RP
    Biochim Biophys Acta; 1986 Jul; 877(3):447-57. PubMed ID: 3089290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid.
    Bach MK; Brashler JR; Gorman RR
    Prostaglandins; 1977 Jul; 14(1):21-38. PubMed ID: 19813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of glutathione requiring enzymes involved in arachidonic acid cascade of rat basophilic leukemia cells.
    Reddy CC; Rao MK; Mastro AM; Egan RW
    Biochem Int; 1984 Dec; 9(6):755-61. PubMed ID: 6441577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of biosynthesis of slow reacting substance to intracellular glutathione concentrations.
    Parker CW; Fischman CM; Wedner HJ
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6870-3. PubMed ID: 6109285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow-reacting substances and asthma: leukotrienes may hold the key to asthma therapy.
    Seale JP
    Med J Aust; 1981 Nov; 2(11):574-5. PubMed ID: 6121283
    [No Abstract]   [Full Text] [Related]  

  • 16. SRS-A and other mediators. Slow reacting substance biosynthesis, characterization and purification.
    Yecies LD; Parker CW
    Monogr Allergy; 1979; 14():155-62. PubMed ID: 41174
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukotrienes: their metabolism, structure, and role in allergic responses.
    Parker CW
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():115-26. PubMed ID: 6124096
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukotrienes.
    Hammarström S
    Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic formation of 14,15-leukotriene A and C(14)-sulfur-linked peptides.
    Sok DE; Han CO; Shieh WR; Zhou BN; Sih CJ
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1363-70. PubMed ID: 6280711
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxidative products of arachidonate: leukotrienes, a new group of compounds, including slow-reacting substance of anaphylaxis (SRA-A).
    Samuelsson B
    Kroc Found Ser; 1981; 14():1-11. PubMed ID: 6118396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.